In a bid to defuse sharp criticism of prescription drug pricing, the nation’s largest pharmacy benefit manager, Express Scripts, and several pharmaceutical companies are teaming up to offer discounts on more than three dozen brand medicines.

The program, called InsideRx, is geared primarily to patients who lack insurance or who have high-deductible health plans, and offers average discounts of 34 percent on medicines for treating diabetes, high cholesterol, acid reflux, and respiratory problems such as asthma.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I have to see it to believe it. Lowering prices many can talk about but walking the talk is a challenge and it is hard. Another question is can they be sustained?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy